Experience in the management of the severe form of human influenza A H1N1 pneumonia in an intensive care unit;Experiencia en el manejo de la forma grave de neumonía por virus de la influenza humana A H1N1 en una unidad de terapia intensiva

Cirugia y Cirujanos

Volumn 79, Issue 5, 2011, Pages 409-416

  Carrillo Esper, Raúl ^a   Ojino Sosa García, Jesús ^a   Arch Tirado, Emilio ^b  

^a LIVER RESEARCH UNIT   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

Author keywords

Influenza A H1N1; Pneumonia

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; BIOLOGICAL MARKER; PLASMA PROTEIN; PRAVASTATIN; PROTEIN C;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD; COMORBIDITY; DISEASE MANAGEMENT; EPIDEMIC; FEMALE; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INTENSIVE CARE; INTENSIVE CARE UNIT; MALE; METHODOLOGY; MEXICO; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OXYGEN THERAPY; RETROSPECTIVE STUDY; STATISTICS; VIRUS PNEUMONIA;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BLOOD PROTEINS; COMBINED MODALITY THERAPY; COMORBIDITY; DISEASE MANAGEMENT; DISEASE OUTBREAKS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MEXICO; MIDDLE AGED; OXYGEN INHALATION THERAPY; PNEUMONIA, VIRAL; PRAVASTATIN; PROTEIN C; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES;

EID: 83455221061     PISSN: 00097411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ayora-Talavera G. Influenza: historia de una enfermedad. Rev Biomed 1999;10:57-61.
2. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine origin H1N1 influenza virus. Nature 2009;459:931-939.
3. Pérez PR, De la Rosa ZD, Ponce de León S, Hernández M, Quiñones FF, Bautista E, et al. Pneumonia and respiratory failure from swineorigin influenza A (H1N1) in Mexico 2009;361:1-10.
4. World Health Organization. Chan M. Influenza A (H1N1). El nivel de alerta de pandemia de gripe se eleva de la fase 5 a la fase 6. Disponible en http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic-phase6- 20090611/es/index.html
5. Secretaría de Salud de México. ¿Cómo se comporta la epidemia de influenza A (H1N1) en México? Disponible en http://portal.salud.gob.mx/contenidos/noticias/influenza/estadisticas.html
6. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 1999;73:5903-5911. (Pubitemid 29274877)
7. Dybing JK, Schultz-Cherry S, Swayne DE, Suárez DL, Perdue ML. Distinct pathogenesis of Hong Kong origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol 2000;74:1443-1450. (Pubitemid 30044094)
8. Zitzow LA, Rowe T, Morken T, Shieh WJ, Zaki S, Katz JM. Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol 2002;76:4420-4429. (Pubitemid 34309579)
9. Tran TH, Nguyen TL, Nguyen TD, Loung TS, Pham PM, Nguyen VC, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004;350:1179-1188.
10. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351:467-471. (Pubitemid 28070092)
11. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1207. (Pubitemid 44527358)
12. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002;360(9348):1831-1837. (Pubitemid 35449422)
13. World Health Organization. Interim WHO guidance for the surveillance of human infection with swine influenza A (H1N1) virus. Disponible en http://www.who.int/csr/disease/swineflu/WHO-case-definitions.pdf
14. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of literature. Clin Infect Dis 2007;44:1084-1089.
15. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712-1719. (Pubitemid 34219772)
16. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome. JAMA 2008;299:637-645. (Pubitemid 351252725)
17. Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome. JAMA 2008;299:646-655. (Pubitemid 351252726)
18. Domínguez CG, Lapinsky SE, Macías AE, Pinto R, Espinoza PL, de la Torre A, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009;302:1880-1887.
19. Gómez GA, Magaña AM, García SC, Ochoa PU, Falcón ER, Comas GA, et al. Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosi, Mexico. Emerg Infect Dis 2010;16:27-34.
20. Rello J, Rodríguez A, Ibáñez P, Socias L, Cebrián J, Marques A, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1) in Spain. Critical Care 2009;13:R148.
21. Bin C, Xingwang L, Yuelong S, Nan J, Shijun C, Xiayuan X, et al. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg Infect Dis 2009;15:1418-1422.
22. Winzer R, Kanig N, Schneitler S, Reuter S, Jensen B, Müller- Stöver I, et al. Early clinical experiences with the new influenza A (H1N1/09). Dtsch Arztebl Int 2009;106:770-776.
23. Rodríguez NE, González DE, Morfín OR, Gómez AG, Briseño RJ, Pérez GH, et al. Hospital triage system for adult patients using an influenza-like illness scoring system during the 2009 pandemic-Mexico. PLoS ONE 2010;5:e10658.
24. Hajjar LA, Schout D, Galas FR, Uip DE, Levin AS, Caiaffa Filho HH, et al. Guidelines on management of human infection with the novel virus influenza a (H1N1)-a report from the Hospital das Clínicas of the University of São Paulo. Clinics 2009;64:1015-1024.
25. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005;353:1374-1385. (Pubitemid 41362705)
26. Centers for Disease Control and Prevention. Intensive care patients with severe novel influenza A (H1N1) virus infection?Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009,58:749-752.
27. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Disease Society of America. Clin Infect Dis 2009;48:1003-1032.
28. WHO. Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and Other Influenza. Geneva: WHO; 2009.
29. Keller TT, van der Sluijs KF, de Kruif MD, Gerdes VE, Meijers JC, Florquin S, et al. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res 2006;99:1261-1269. (Pubitemid 44808663)
30. Vincent JL, Angus DC, Artigas A, Kalil A, Basson BR, Jamal HH, et al. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003;31:834-840. (Pubitemid 36379592)
31. Fedson DS. Statin protection against influenza and COPD mortality. Chest 2007;132;1406-1407.
32. Almog Y. Statins, inflammation, and sepsis. Chest 2003;124;740-743.
33. Warnholtz A, Genth-Zotz S, Münzel T. Should treatment of sepsis includes statins? Circulation 2005;111:1735-1737. (Pubitemid 40525136)
34. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009;37:1-10.